Single-cell analysis of FOXP3 deficiencies in humans and mice unmasks intrinsic and extrinsic CD4+ T cell perturbations.
David ZemmourLouis-Marie CharbonnierJuliette LeonEmmanuelle SixSevgi KelesMarianne DelvilleMehdi BenamarSafa BarışJulien ZuberKarin ChenBenedicte NevenMaria I Garcia-LloretFrank M RuemmeleCarlo BrugnaraNadine Cerf-BensussanFrederic Rieux-LaucatMarina CavazzanaIsabelle AndréTalal A ChatilaDiane MathisChristophe BenoistPublished in: Nature immunology (2021)
FOXP3 deficiency in mice and in patients with immune dysregulation polyendocrinopathy enteropathy X-linked (IPEX) syndrome results in fatal autoimmunity by altering regulatory T (Treg) cells. CD4+ T cells in patients with IPEX syndrome and Foxp3-deficient mice were analyzed by single-cell cytometry and RNA-sequencing, revealing heterogeneous Treg-like cells, some very similar to normal Treg cells, others more distant. Conventional T cells showed no widespread activation or helper T cell bias, but a monomorphic disease signature affected all CD4+ T cells. This signature proved to be cell extrinsic since it was extinguished in mixed bone marrow chimeric mice and heterozygous mothers of patients with IPEX syndrome. Normal Treg cells exerted dominant suppression, quenching the disease signature and revealing in mutant Treg-like cells a small cluster of genes regulated cell-intrinsically by FOXP3, including key homeostatic regulators. We propose a two-step pathogenesis model: cell-intrinsic downregulation of core FOXP3-dependent genes destabilizes Treg cells, de-repressing systemic mediators that imprint the disease signature on all T cells, furthering Treg cell dysfunction. Accordingly, interleukin-2 treatment improved the Treg-like compartment and survival.
Keyphrases
- single cell
- regulatory t cells
- induced apoptosis
- rna seq
- cell cycle arrest
- cell therapy
- bone marrow
- high throughput
- transcription factor
- signaling pathway
- stem cells
- oxidative stress
- lymph node
- mesenchymal stem cells
- immune response
- case report
- genome wide
- metabolic syndrome
- cell death
- adipose tissue
- combination therapy